The FDA has released guidelines for PET drug manufacturers, establishing a December 2015 deadline for them to secure a new drug application, an abbreviated new drug application or an effective investigational new drug application for PET drugs already being used in the clinical setting. The guidelines include recommendations on the steps companies should take in submitting applications and the required safety data.
FDA gives PET drugmakers until end of 2015 to secure NDA
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||